<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 9">
<meta name=Originator content="Microsoft Word 9">
<link rel=File-List href="./Page3_files/filelist.xml">
<link rel=Edit-Time-Data href="./Page3_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<title> </title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>jennifer</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>jennifer</o:LastAuthor>
  <o:Revision>12</o:Revision>
  <o:TotalTime>70</o:TotalTime>
  <o:Created>2006-05-10T09:48:00Z</o:Created>
  <o:LastSaved>2006-05-10T14:14:00Z</o:LastSaved>
  <o:Pages>2</o:Pages>
  <o:Words>670</o:Words>
  <o:Characters>3822</o:Characters>
  <o:Company>EMBL-EBI</o:Company>
  <o:Lines>31</o:Lines>
  <o:Paragraphs>7</o:Paragraphs>
  <o:CharactersWithSpaces>4693</o:CharactersWithSpaces>
  <o:Version>9.6926</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:Zoom>75</w:Zoom>
 </w:WordDocument>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
@font-face
	{font-family:"Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1 -369098753 63 0 4129023 0;}
@font-face
	{font-family:"\@Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1 -369098753 63 0 4129023 0;}
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:16.0pt;
	font-family:Arial;
	mso-fareast-font-family:"Arial Unicode MS";
	mso-font-kerning:16.0pt;}
h2
	{mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:14.0pt;
	font-family:Arial;
	mso-fareast-font-family:"Arial Unicode MS";
	font-style:italic;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:595.3pt 841.9pt;
	margin:72.0pt 90.0pt 72.0pt 90.0pt;
	mso-header-margin:35.4pt;
	mso-footer-margin:35.4pt;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1027"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-GB link=blue vlink=purple style='tab-interval:36.0pt'>

<div class=Section1>

<p class=MsoNormal><a href="http://www.ebi.ac.uk/interpro/"
title="To the InterPro database"><span style='www.ebi.ac.uk/interpro/index.html'><span
style='text-decoration:none;text-underline:none'><!--[if gte vml 1]><v:shapetype
 id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t"
 path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:139.5pt;
 height:45pt'>
 <v:imagedata src="./Page3_files/image001.png" o:title="InterPro"/>
</v:shape><![endif]--><![if !vml]><img border=0 width=186 height=60
src="./Page3_files/image002.jpg" v:shapes="_x0000_i1025"><![endif]></span></span></a></p>

<h1 align=center style='text-align:center'><span style='font-size:28.0pt;
mso-bidi-font-size:16.0pt;color:navy'>Bird Flu - Haemagglutinin<o:p></o:p></span></h1>

<p class=MsoNormal>&nbsp;</p>

<h2><span style='color:navy;font-style:normal'>Haemagglutinin, the Key to Infection<o:p></o:p></span></h2>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal style='text-align:justify'><span style='mso-tab-count:1'>            </span>Haemagglutinin
is key to the infectivity of influenza A virus.<span style="mso-spacerun:
yes">  </span>A surface fusion glycoprotein embedded in the envelope of the
virus, haemagglutinin must first be cleaved by the host’s trypsin-like
proteases for the virus to be infectious.<span style="mso-spacerun: yes"> 
</span>In fact, the infectivity and pathogenicity of the virus is largely
determined by the host’s trypsin-like proteases.<span style="mso-spacerun:
yes">  </span>The processing of haemagglutinin by these proteases takes place
on the membranes of the host’s airway epithelial cells, where haemagglutinin
glycoprotein (HA<sub>0</sub>) is cleaved to produce HA<sub>1</sub> and HA<sub>2</sub>
peptides.<span style="mso-spacerun: yes">  </span>The newly exposed N-terminal
of the HA<sub>2</sub> fusion peptide then acts to fuse the viral envelope to
the cellular membrane of the host cell.<span style="mso-spacerun: yes"> 
</span>Once the membranes have fused, the virus’ genetic material,
negative-stranded RNA, can invade and take control of the host cell.<span
style="mso-spacerun: yes">  </span></p>

<p class=MsoBodyText style='text-indent:36.0pt'>&nbsp;</p>

<h2><span style='color:navy;font-style:normal'>Haemagglutinin and Pathogenicity<o:p></o:p></span></h2>

<p class=MsoBodyText>&nbsp;</p>

<p class=MsoBodyText><span style='mso-tab-count:1'>            </span>Both the
type and distribution of trypsin-like proteases in the host, as well as the
susceptibility of HA<sub>0</sub> to these enzymes, determine the infectivity
and pathogenicity of the influenza virus.<span style="mso-spacerun: yes"> 
</span>Several different trypsin-like proteases can act on haemagglutinin, where
both the tissues in which they act (e.g. epithelial or neuronal cell) and the
position of cleavage of HA will affect the infectivity of the virus.<span
style="mso-spacerun: yes">  </span>For instance, proteases present in the brain
can cause the infection to take root there (in addition to epithelial cells),
while the position of cleavage by the protease can determine how well it binds
to receptors on the host cell in order to infect it.<span style="mso-spacerun:
yes">  </span>Trypsin-like proteases known to cleave HA<sub>0</sub> include
tryptase Clara, mini-plasmin, ectopic anionic trypsin, mast cell tryptase,
tryptase TC30, and brain trypsin I, the latter being a possible candidate for
the rare cases of encephalitis that are associated with certain strains of the
virus.<span style="mso-spacerun: yes">  </span>Most strains of influenza A are
pneumotropic, localising the infection to airway epithelial cells, but a few
strains can multiply in both airway epithelial cells and in neuronal cells,
causing life-threatening encephalitis, such as occurred in the devastating 1918
<i>Spanish</i> <i>Influenza</i> pandemic.<span style="mso-spacerun: yes"> 
</span></p>

<p class=MsoBodyText><span style='mso-tab-count:1'>            </span>Haemagglutinin
itself also determines the pathogenicity of the virus, which varies from
avirulent strains to lethal ones, providing a genetic mechanism for the
variation in viral virulence (although other viral proteins affect virulence as
well). The differences between strains are primarily determined by the amino
acid sequence at the HA<sub>0</sub> cleavage site, where the precise linkage of
HA to host receptors determines species preference.<span style="mso-spacerun:
yes">  </span>For example, a switch in receptor specificity from receptors
containing sialic acids connected to galactose in a <span style='font-family:
Symbol'>a</span>2-3 linkage (avian receptors) to a <span style='font-family:
Symbol'>a</span>2-6 linkage (human receptors) is required for influenza A virus
to cross the species barrier in adapting to a human host – this requires
adaptation in the binding capacity of HA.</p>

<p class=MsoBodyText>&nbsp;</p>

<h2><span style='color:navy;font-style:normal'>Neuraminidase, a Supporting Role<o:p></o:p></span></h2>

<p class=MsoBodyText>&nbsp;</p>

<p class=MsoBodyText><span style='mso-tab-count:1'>            </span>The
second major surface glycoprotein found on the influenza A viral envelope is
neuraminidase. <span style="mso-spacerun: yes"> </span>This protein promotes
the release of progeny virus from the host cell during the final stages of viral
replication.<span style="mso-spacerun: yes">  </span>In addition, there is
increasing evidence that neuraminidase can promote virus entry into host cells during
the initial stage of infection.<span style="mso-spacerun: yes">  </span></p>

<p class=MsoBodyText><span style='mso-tab-count:1'>            </span>In
particular, when a variant of the 1918 <i>Spanish Influenza</i> pandemic strain
H1N1 was analysed, the neuraminidase was found to directly bind plasminogen,
sequestering the protease precursor to achieve a higher local
concentration.<span style="mso-spacerun: yes">  </span>The active form of the
protease, plasmin, could then cleave and activate haemagglutinin, thereby
promoting the viral infection of host cells. <span style="mso-spacerun:
yes"> </span>This unusual function of neuraminidase was found to have a molecular
basis, involving the appearance of a C-terminal lysine and the absence of an
oligosaccharide side chain at another position on the neuraminidase molecule.<span
style="mso-spacerun: yes">  </span>Such changes allowed the virus to infect
cells other than its usual targets, and showed a possible means of how the
virus could become highly pathogenic in humans.</p>

<p class=MsoBodyText><span style='mso-tab-count:1'>            </span>Therefore,
the ability of influenza A virus to cross the species barrier to yield a human-adapted
variant involves several mechanisms, including variation in host proteases,
variations in viral haemagglutinin and neuraminidase, as well as variations in several
other viral proteins, not to mention the complex interplay of environmental
factors.</p>

<p class=MsoBodyText><span style='mso-tab-count:1'>            </span></p>

<h2 align=center style='text-align:center'><span style='font-style:normal'>Next:<span
style="mso-spacerun: yes">  </span><a href="Page4.htm">What InterPro Tells Us</a><o:p></o:p></span></h2>

<h2 align=center style='text-align:center'><span style='font-style:normal'>Previous:<span
style="mso-spacerun: yes">  </span><a href="Page2.htm">Crossing the Species Barrier</a><o:p></o:p></span></h2>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

</div>

</body>

</html>
